title: Ponatinib in chronic myeloid leukaemia: ready for first-line?
authors.affiliation: Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome 00161, Italy. Electronic address: breccia@bce.uniroma1.it.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.affiliation: Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome 00161, Italy.
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive